An­oth­er four biotechs scratch out the first num­ber and ask for more as IPO boom con­tin­ues

Four more biotechs are rais­ing their of­fers in an al­ready record year for biotech IPOs.

Soft­bank-backed Re­lay Ther­a­peu­tics scratched out its orig­i­nal $200 mil­lion …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.